LCM(Laser Capture Microdissection) 시장 보고서 : 제품 유형별, 시스템 유형별, 용도별, 최종사용자별, 지역별(2026-2034년)

The global laser capture microdissection market size reached USD 176.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 379.6 Million by 2034, exhibiting a growth rate (CAGR) of 8.50% during 2026-2034. The increasing demand for personalized medicines, expanding cancer research, significant growth in biomarker discovery, and advancements in drug development are primarily propelling the market's growth.

LASER CAPTURE MICRODISSECTION MARKET ANALYSIS:

• Major Market Drivers: The growing utilization of molecular analysis in a bioscience research laboratory, along with the expanding healthcare industry, represent some of the key factors driving the market. Moreover, as LCM allows precise vivo examination of cell populations, such as malignant cells of Hodgkin's disease and carcinoma in situ with sensitive analytical techniques, its sales are rising across the globe.
• Key Market Trends: There is an increase in healthcare expenditure and R&D funding by governments of several countries. This, along with the escalating demand for LCM in forensic science and molecular biology centers to obtain interpretable DNA profiles, is stimulating the market growth. Moreover, key market players are introducing enhanced LCM technologies equipped with immunofluorescence laser diodes for improved biomarker discovery and cancer chemoprevention, which is projected to bolster the growth of the market.
• Competitive Landscape: Some of the prominent laser capture microdissection market companies include AnaPath Services GmbH, CaresBio Laboratory, DH Life Sciences, LLC, Epistem Ltd, Gnome Diagnostics & Gnome Sciences, Laxco, Inc., Leica Microsystems, Molecular Machines & Industries, Thermo Fisher Scientific Inc., and VitroVivo Biotech, among many others.
• Geographical Trends: According to the laser capture microdissection market dynamics, North America dominates the overall market. Genomic and proteomic research, especially related to genetic disorders, is expanding in North America. LCM facilitates these studies by enabling researchers to collect cells with minimal contamination, which is crucial for DNA, RNA, and protein analysis.
• Challenges and Opportunities: The high cost of instruments and increasing competition among alternative technologies are hampering the market's growth. However, the increasing focus on genomic and proteomic analysis to study cellular mechanisms, especially in diseases like cancer, neurological disorders, and rare genetic diseases, presents a significant opportunity for LCM.

LASER CAPTURE MICRODISSECTION MARKET TRENDS:

Rising Incidence of Cancer

The rising incidence of cancer and other chronic diseases has increased the need for precise cellular analysis. There has been a significant number of cancer patients across various regions. For instance, according to American Cancer Society Journals, in 2024, the United States is expected to see 2,001,000 new cancer cases and 611,700 cancer deaths. LCM is used extensively to capture and study cancerous cells, especially for tumor profiling, genetic mutations, and other diagnostic purposes. These factors are expected to propel the laser capture microdissection market share in the coming years.

Expanding Biobanking Industry

The growing biobanking industry is one of the key factors driving the market growth. For instance, according to IMARC, the global biobanking market size reached US$ 61.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 99.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. Biobanks store vast amounts of biological samples, which researchers use for studying disease mechanisms, drug development, and biomarker discovery. LCM is critical for preparing these samples by enabling the precise isolation of specific cells from heterogeneous tissue samples. These factors further positively influence the laser capture microdissection market price.

Increasing Investment in R&D

Governments, research institutions, and private companies are heavily investing in R&D to advance precision medicine and genomics. For instance, in September 2024, TVM Capital Healthcare, an international growth capital firm focused on healthcare, made a significant equity investment in San Francisco-based Human Longevity, Inc. (HLI), a global precision medicine and longevity science company. LCM technology plays a pivotal role in precision medicine areas, as it enables researchers to isolate specific cells for genetic analysis and study of disease mechanisms. The precision of LCM supports the development of personalized treatment plans, making it a key tool in genomic research, thereby boosting the laser capture microdissection market revenue.

GLOBAL LASER CAPTURE MICRODISSECTION MARKET SEGMENTATION:

Breakup by Product:

• Instruments
• Consumables
• Software and Services

According to the laser capture microdissection market outlook, instruments form the core of LCM technology, including the laser systems, microscopes, and automation tools that enable precise cell and tissue capture. Modern LCM instruments have become more advanced with features like high-resolution imaging, automated sample handling, and integration with other lab equipment. The demand is driven by the need for these sophisticated tools that enhance precision, speed, and efficiency in capturing cells from complex tissues. Moreover, consumables are essential for daily research and experimental activities in genomics, proteomics, and cell biology. The growing number of research projects in universities, research institutions, and biotech companies increases the demand for LCM consumables.

Breakup by System Type:

• Ultraviolet LCM
• Infrared LCM
• Others

Ultraviolet LCM currently holds the majority of the total market share

According to the laser capture microdissection market overview, UV LCM technology is known for its high precision in cutting and capturing cells with minimal thermal damage to the surrounding tissues. This makes it ideal for applications where maintaining cell integrity is crucial, such as in genetic and molecular analysis. Moreover, neurological disorders like Alzheimer's, Parkinson's, and multiple sclerosis require the analysis of specific neurons and brain tissue regions. UV LCM is widely used in neuroscience research to dissect precise areas of brain tissues, enabling researchers to study disease pathology at the cellular level.

Breakup by Application:

• Research and Development
• Diagnostics
• Others

Research and development exhibits clear dominance in the market

LCM technology is highly valued in genomics research for isolating pure cell populations to perform DNA, RNA, and protein analysis. The precision offered by LCM is essential for generating high-quality data in genetic sequencing, transcriptomics, and epigenetic studies, driving its adoption in R&D. Moreover, precision medicine aims to develop tailored treatment strategies based on an individual's genetic makeup and cellular characteristics. LCM supports these efforts by providing specific cell samples that are crucial for understanding patient-specific disease mechanisms and drug response, driving its increased use in R&D.

Breakup by End User:

• Hospitals
• Academic and Government Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)

Academic and government research institutes account for the largest market share

Academic and government research institutes are at the forefront of exploring fundamental biological processes. LCM plays a critical role in isolating specific cells from complex tissues, allowing researchers to study cell behavior, gene expression, and protein interactions at the molecular level. Moreover, cancer research is a major focus in both academic and government research institutions. LCM is a key tool for isolating cancer cells from surrounding tissues to study tumor heterogeneity, gene mutations, and the molecular mechanisms driving cancer progression. As these institutions receive substantial government funding for cancer research, the demand for LCM technology rises.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America currently dominates the global market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America currently dominates the global market.

According to the laser capture microdissection market statistics, North America, especially the United States, is a global leader in personalized medicine. LCM technology plays a critical role in isolating specific cells from tissues for genomic and molecular analysis, which is essential for tailoring treatment to individual patients. The increasing focus on personalized healthcare is driving the demand for LCM technology in both research and clinical settings. Moreover, LCM is widely used for tumor profiling, identifying cancer biomarkers, and studying tumor microenvironments, which are key to developing personalized cancer treatments. The rising adoption of precision oncology across North America is a significant growth driver for the LCM market.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

• AnaPath Services GmbH
• CaresBio Laboratory
• DH Life Sciences, LLC
• Epistem Ltd
• Gnome Diagnostics & Gnome Sciences
• Laxco, Inc.
• Leica Microsystems
• Molecular Machines & Industries
• Thermo Fisher Scientific Inc.
• VitroVivo Biotech

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global laser capture microdissection market in 2025?

2. What is the expected growth rate of the global laser capture microdissection market during 2026-2034?

3. What has been the impact of COVID-19 on the global laser capture microdissection market?

4. What are the key factors driving the global laser capture microdissection market?

5. What is the breakup of the global laser capture microdissection market based on the system type?

6. What is the breakup of the global laser capture microdissection market based on the application?

7. What is the breakup of the global laser capture microdissection market based on the end user?

8. What are the key regions in the global laser capture microdissection market?

9. Who are the key players/companies in the global laser capture microdissection market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Laser Capture Microdissection Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Instruments
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Consumables
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Software and Services
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by System Type

• 7.1 Ultraviolet LCM
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Infrared LCM
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Research and Development
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Diagnostics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Academic and Government Research Institutes
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Pharmaceutical and Biotechnology Companies
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Contract Research Organizations (CROs)
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 AnaPath Services GmbH
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 CaresBio Laboratory
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 DH Life Sciences, LLC
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Epistem Ltd
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Gnome Diagnostics & Gnome Sciences
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Laxco, Inc.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Leica Microsystems
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Molecular Machines & Industries
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Thermo Fisher Scientific Inc.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 VitroVivo Biotech
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio